Right ventricular mechanical support for pulmonary arterial hypertension. The low flow concept. KU Leuven
Pulmonary arterial hypertension (PAH) is caused by a pathological increase in pulmonary vascular resistance (PVR) and ultimately leads to right ventricular (RV) failure. On modern therapy, there is still 15% mortality within 1 year and median survival remains limited to 5-6 years, with insufficient functional improvement in many survivors. Bilateral lung transplantation (bLTx) remains the only curative option. Unfortunately, most patients are ...